Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-08 Purchase | 2022-08-09 5:23 pm | RVL Pharmaceuticals plc | RVLP | Schaub James COO | 150,000 | $1.55 | $232,500 | 540,020 (Direct) | View |
| 2022-08-08 Purchase | 2022-08-09 5:22 pm | RVL Pharmaceuticals plc | RVLP | MARKISON BRIAN A CEO | 850,000 | $1.55 | $1,317,500 | 2,976,020 (Direct) | View |
| 2022-08-08 Purchase | 2022-08-09 5:21 pm | RVL Pharmaceuticals plc | RVLP | Burgstahler David F Director 10% Owner | 8,000,000 | $1.55 | $12,400,000 | 24,763,859 (Indirect) | View |
| 2022-08-08 Purchase | 2022-08-09 5:19 pm | RVL Pharmaceuticals plc | RVLP | Venkataraman Sriram Director 10% Owner | 8,000,000 | $1.55 | $12,400,000 | 24,763,859 (Indirect) | View |
| 2022-08-08 Purchase | 2022-08-09 5:18 pm | RVL Pharmaceuticals plc | RVLP | Avista Healthcare Partners L.P. Avista Healthcare Partners GP Ltd. Avista Capital Partners III GP L.P. Orbit Co-Invest III LLC 10% Owner | 8,000,000 | $1.55 | $12,400,000 | 24,763,859 (Indirect Direct) | View |
| 2021-12-16 Purchase | 2021-12-20 5:03 pm | Osmotica Pharmaceuticals plc | OSMT | Schaub James COO | 93,800 | $1.07 | $100,366 | 405,900 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-10 Option Award | 2022-08-12 4:07 pm | N/A N/A | RVL Pharmaceuticals plc | RVLP | Lask Alisa Director | 75,000 | $0 | 84,557 (Direct) | View |
| 2022-08-10 Ownership | 2022-08-12 4:05 pm | N/A N/A | RVL Pharmaceuticals plc | RVLP | Lask Alisa Director | 0 | $0 | 9,557 (Direct) | View |
| 2022-08-08 Ownership | 2022-08-12 11:37 am | N/A N/A | RVL Pharmaceuticals plc | RVLP | Athyrium Opportunities IV Acquisition 2 LP Athyrium Opportunities IV Co-invest 2 LP Athyrium Opportunities Associates IV LP Athyrium Opportunities Associates IV GP LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates IV Co-Invest LLC Ferrell Jeffrey 10% Owner | 0 | $0 | 16,600,444 (Indirect) | View |
| 2022-05-18 Tax Withholding | 2022-05-20 4:28 pm | N/A N/A | RVL Pharmaceuticals plc | RVLP | deVries Tina Marie VP | 5,447 | $1.4 | 136,141 (Direct) | View |
| 2022-05-18 Tax Withholding | 2022-05-20 4:27 pm | N/A N/A | RVL Pharmaceuticals plc | RVLP | Klein Christopher General Counsel & Secretary | 6,127 | $1.4 | 195,628 (Direct) | View |
| 2022-05-18 Tax Withholding | 2022-05-20 4:25 pm | N/A N/A | RVL Pharmaceuticals plc | RVLP | Schaub James COO | 6,273 | $1.4 | 390,020 (Direct) | View |
| 2022-01-24 Tax Withholding | 2022-01-26 4:31 pm | N/A N/A | RVL Pharmaceuticals plc | RVLP | Einhorn Andrew J. CFO | 9,607 | $1.13 | 164,325 (Direct) | View |
| 2022-01-24 Tax Withholding | 2022-01-26 4:31 pm | N/A N/A | RVL Pharmaceuticals plc | RVLP | Klein Christopher General Counsel & Secretary | 9,607 | $1.13 | 201,755 (Direct) | View |
| 2022-01-24 Tax Withholding | 2022-01-26 4:31 pm | N/A N/A | RVL Pharmaceuticals plc | RVLP | deVries Tina Marie VP | 9,607 | $1.13 | 141,588 (Direct) | View |
| 2022-01-24 Tax Withholding | 2022-01-26 4:30 pm | N/A N/A | RVL Pharmaceuticals plc | RVLP | Schaub James COO | 9,607 | $1.13 | 396,293 (Direct) | View |
| 2021-11-04 Option Award | 2021-11-08 4:09 pm | N/A 2031-11-04 | Osmotica Pharmaceuticals plc | OSMT | deVries Tina Marie VP | 216,944 | $0 | 216,944 (Direct) | View |
| 2021-11-04 Option Award | 2021-11-08 4:07 pm | N/A 2031-11-04 | Osmotica Pharmaceuticals plc | OSMT | Schaub James COO | 249,814 | $0 | 249,814 (Direct) | View |
| 2021-11-04 Option Award | 2021-11-08 4:06 pm | N/A 2031-11-04 | Osmotica Pharmaceuticals plc | OSMT | Klein Christopher General Counsel & Secretary | 249,814 | $0 | 249,814 (Direct) | View |
| 2021-11-04 Option Award | 2021-11-08 4:06 pm | N/A 2031-11-04 | Osmotica Pharmaceuticals plc | OSMT | Einhorn Andrew J. CFO | 249,814 | $0 | 249,814 (Direct) | View |
| 2021-11-04 Option Award | 2021-11-08 4:05 pm | N/A 2031-11-04 | Osmotica Pharmaceuticals plc | OSMT | MARKISON BRIAN A CEO | 615,000 | $0 | 615,000 (Direct) | View |
| 2021-08-27 Tax Withholding | 2021-09-03 4:02 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | COWAN GREGORY L Director | 5,506 | $3.31 | 50,055 (Direct) | View |
| 2021-08-27 Tax Withholding | 2021-09-03 4:01 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | WEISS FRED G Director | 5,506 | $3.31 | 118,466 (Direct) | View |
| 2021-07-02 Option Award | 2021-07-07 4:05 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | WEISS FRED G Director | 61,188 | $0 | 123,972 (Direct) | View |
| 2021-06-18 Tax Withholding | 2021-06-22 4:06 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | WEISS FRED G Director | 18,584 | $2.89 | 62,784 (Direct) | View |
| 2021-06-18 Tax Withholding | 2021-06-22 4:05 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | COWAN GREGORY L Director | 18,584 | $2.89 | 55,561 (Direct) | View |
| 2021-05-18 Tax Withholding | 2021-05-20 4:07 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | Schaub James COO | 6,621 | $3.12 | 312,100 (Direct) | View |
| 2021-05-18 Tax Withholding | 2021-05-20 4:06 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | Klein Christopher General Counsel & Secretary | 6,467 | $3.12 | 211,362 (Direct) | View |
| 2021-05-18 Tax Withholding | 2021-05-20 4:06 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | Einhorn Andrew J. CFO | 6,467 | $3.12 | 173,932 (Direct) | View |
| 2021-05-18 Tax Withholding | 2021-05-20 4:05 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | deVries Tina Marie VP | 6,467 | $3.12 | 151,195 (Direct) | View |
| 2021-01-24 Tax Withholding | 2021-01-26 7:03 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | Schaub James COO | 9,687 | $4.46 | 318,721 (Direct) | View |
| 2021-01-24 Tax Withholding | 2021-01-26 7:03 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | Klein Christopher General Counsel & Secretary | 9,605 | $4.46 | 217,829 (Direct) | View |
| 2021-01-24 Tax Withholding | 2021-01-26 7:02 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | Einhorn Andrew J. CFO | 9,668 | $4.46 | 180,399 (Direct) | View |
| 2021-01-24 Tax Withholding | 2021-01-26 7:01 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | deVries Tina Marie VP | 9,597 | $4.46 | 157,662 (Direct) | View |
| 2021-01-24 Tax Withholding | 2021-01-26 7:01 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | WEISS FRED G Director | 5,505 | $4.46 | 81,368 (Direct) | View |
| 2021-01-24 Tax Withholding | 2021-01-26 7:00 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | COWAN GREGORY L Director | 5,505 | $4.46 | 74,145 (Direct) | View |
| 2020-11-20 Other | 2020-11-23 5:13 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | Venkataraman Sriram Director 10% Owner | 4,936,926 | $0 | 21,700,785 (Indirect) | View |
| 2020-11-20 Other | 2020-11-23 5:11 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | Burgstahler David F Director 10% Owner | 4,936,926 | $0 | 21,700,785 (Indirect) | View |
| 2020-11-20 Other | 2020-11-23 5:10 pm | N/A N/A | Osmotica Pharmaceuticals plc | OSMT | Avista Capital Partners III GP L.P. Avista Healthcare Partners GP Ltd. Avista Healthcare Partners L.P. Orbit Co-Invest III LLC 10% Owner | 4,936,926 | $0 | 21,700,785 (Indirect) | View |